Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellgram-ED for Erectile Dysfunction
NCT02344849Phase 1Completed
- Sponsor
- Pharmicell Co., Ltd.
- Start
- Jul 2015
- Primary completion
- Jan 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Cellgram ED in erectile dysfunction (ED), sponsored by Pharmicell Co., Ltd. Primary endpoint: Number and severity of adverse events at 12 months. Started Jul 2015; status: completed.
02
Drugs
Cellgram ED
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02344849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344849.